Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus dexmedetomidine for emergence agitation after pediatric tonsillectomy and adenoidectomy
ChiCTR2300067522Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and esketamine in Emergence agitation (EA) (3 arms), sponsored by The First Hospital of Fujian Medical University. Primary endpoint: Incidence of emergence agitation after pediatric tonsillectomy and adenoidectomy. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2300067522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067522.